LV10107B - Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome - Google Patents

Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome Download PDF

Info

Publication number
LV10107B
LV10107B LVP-92-320A LV920320A LV10107B LV 10107 B LV10107 B LV 10107B LV 920320 A LV920320 A LV 920320A LV 10107 B LV10107 B LV 10107B
Authority
LV
Latvia
Prior art keywords
peptide
amino acid
derivative
optionally
acm
Prior art date
Application number
LVP-92-320A
Other languages
English (en)
Latvian (lv)
Other versions
LV10107A (lv
Inventor
Fred Widmer
Kailash Kumar Gauri
Stig Aasmul-Olsen
Original Assignee
Carlbiotech Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carlbiotech Ltd As filed Critical Carlbiotech Ltd As
Publication of LV10107A publication Critical patent/LV10107A/xx
Publication of LV10107B publication Critical patent/LV10107B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LVP-92-320A 1989-12-07 1992-12-17 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome LV10107B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK615889A DK167813B1 (da) 1989-12-07 1989-12-07 Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
PCT/DK1990/000322 WO1991009053A1 (fr) 1989-12-07 1990-12-07 Derive peptidique, son procede de preparation, preparation pharmaceutique le contenant et procede du traitement du glaucome

Publications (2)

Publication Number Publication Date
LV10107A LV10107A (lv) 1994-05-10
LV10107B true LV10107B (en) 1995-02-20

Family

ID=8147734

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-320A LV10107B (en) 1989-12-07 1992-12-17 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucome

Country Status (12)

Country Link
US (1) US5411942A (fr)
EP (1) EP0504207B1 (fr)
JP (1) JPH05504336A (fr)
KR (1) KR927003631A (fr)
AT (1) ATE149517T1 (fr)
CA (1) CA2069449A1 (fr)
DE (1) DE69030100D1 (fr)
DK (1) DK167813B1 (fr)
FI (1) FI922620A0 (fr)
HU (1) HUT61322A (fr)
LV (1) LV10107B (fr)
WO (1) WO1991009053A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776892A (en) * 1990-12-21 1998-07-07 Curative Health Services, Inc. Anti-inflammatory peptides
DK53291D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
DK53191D0 (da) * 1991-03-25 1991-03-25 Carlbiotech Ltd As Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5968904A (en) * 1993-06-04 1999-10-19 Demegen, Inc. Modified arginine containing lytic peptides and method of making the same by glyoxylation
US5773413A (en) * 1993-06-04 1998-06-30 Demeter Biotechnologies, Ltd. Method of combating mammalian neoplasias, and lytic peptides therefor
CN1315870C (zh) 1995-06-07 2007-05-16 葛兰素集团有限公司 结合血小板生成素受体的肽和化合物
US7091311B2 (en) * 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
US8283315B2 (en) * 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) * 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
ES2462916T3 (es) 2002-09-18 2014-05-26 Janssen Pharmaceuticals, Inc. Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
US20040171554A1 (en) * 2003-02-07 2004-09-02 Genentech, Inc. Compositions and methods for enhancing apoptosis
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
SI1675606T1 (sl) * 2003-08-28 2017-07-31 Janssen Pharmaceuticals, Inc. Peptidi in spojine, ki se vežejo na trombopoietinske receptorje
JP5122275B2 (ja) * 2004-03-23 2013-01-16 ジェネンテック， インコーポレイテッド Ｉａｐのアザビシクロ−オクタンインヒビター
KR20080083220A (ko) 2004-04-07 2008-09-16 노파르티스 아게 Ｉａｐ 억제제
WO2006014361A1 (fr) * 2004-07-02 2006-02-09 Genentech, Inc. Inhibiteurs de pai
US20060210542A1 (en) * 2004-08-16 2006-09-21 Yurkow Edward J Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
ES2349110T5 (es) 2004-12-20 2013-11-27 Genentech, Inc. Inhibidores de IAP derivados de pirrolidina
CN101374829A (zh) * 2005-12-19 2009-02-25 健泰科生物技术公司 Iap的抑制剂
PE20110217A1 (es) 2006-08-02 2011-04-01 Novartis Ag DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
KR20090094461A (ko) * 2006-12-19 2009-09-07 제넨테크, 인크. Ｉａｐ의 이미다조피리딘 억제제
JP2010524467A (ja) * 2007-04-16 2010-07-22 モメンタ ファーマシューティカルズ インコーポレイテッド 規定の糖タンパク質産物および関連の方法
TWI432212B (zh) * 2007-04-30 2014-04-01 Genentech Inc Ｉａｐ抑制劑
SI2240506T1 (sl) * 2008-01-11 2013-04-30 Genentech, Inc. Inhibitorji IAP
EP2318395A4 (fr) 2008-08-02 2011-10-26 Genentech Inc Inhibiteurs d'iap
NZ590500A (en) * 2008-08-16 2012-06-29 Genentech Inc Azaindole inhibitors of iap
ES2602108T3 (es) 2010-04-07 2017-02-17 Momenta Pharmaceuticals, Inc. Método para cuantificar glicoformas que contienen alta manosa
WO2012125553A2 (fr) 2011-03-12 2012-09-20 Momenta Pharmaceuticals, Inc. N-glycanes contenant de la n-acétylhexosamine dans des produits de glycoprotéines
WO2013181575A2 (fr) 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Méthodes associées au denosumab
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
EP2996772B1 (fr) 2013-05-13 2018-12-19 Momenta Pharmaceuticals, Inc. Méthodes de traitement de la neurodégénérescence
EP3058084A4 (fr) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Glycoprotéines sialylées
KR20230005177A (ko) * 2020-03-25 2023-01-09 아우프바우 메디컬 이노베이션스 리미티드 녹내장을 위한 방법 및 작용제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457489A (en) * 1981-07-13 1984-07-03 Gilmore Samuel E Subsea fluid conduit connections for remote controlled valves
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
US4559340A (en) * 1983-11-25 1985-12-17 Schering Corporation Antihypertensive agents
US4634698A (en) * 1984-09-24 1987-01-06 Schering Corporation Antiglaucoma agents
EP0210204B1 (fr) * 1985-01-18 1988-12-07 Kailash Kumar Dr. Prof. Gauri Hydrolysats de proteine, leur procede de production et medicaments les contenant
IL86386A0 (en) * 1987-05-21 1988-11-15 Merrell Dow Pharma Novel anf derivatives
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0504207B1 (fr) 1997-03-05
AU636427B2 (en) 1993-04-29
HUT61322A (en) 1992-12-28
US5411942A (en) 1995-05-02
DK615889A (da) 1991-06-08
HU9201883D0 (en) 1992-09-28
FI922620A (fi) 1992-06-05
ATE149517T1 (de) 1997-03-15
DE69030100D1 (de) 1997-04-10
DK615889D0 (da) 1989-12-07
WO1991009053A1 (fr) 1991-06-27
LV10107A (lv) 1994-05-10
JPH05504336A (ja) 1993-07-08
FI922620A0 (fi) 1992-06-05
DK167813B1 (da) 1993-12-20
AU6898991A (en) 1991-07-18
KR927003631A (ko) 1992-12-18
CA2069449A1 (fr) 1991-06-08
EP0504207A1 (fr) 1992-09-23

Similar Documents

Publication Publication Date Title
US5411942A (en) Peptide derivative, pharmaceutical preparation containing it and method for treatment of glaucoma
FI79854B (fi) Foerfarande foer framstaellning av ett laekemedelspreparat som innehaoller ett insulinderivat.
JP3445269B2 (ja) インスリン様成長因子およびアナログの適用による網膜ニューロン障害の治療
US7795222B2 (en) Methods for treating a corneal disorder and promoting skin wound healing
US9938320B2 (en) Peptides for promoting angiogenesis and use thereof
CA2835369A1 (fr) Fragments peptidiques destines a induire la synthese de proteines matricielles extracellulaires
US5231082A (en) Cyclic peptide with anti-metastasis activity
US5464821A (en) Small peptidic compounds useful for the treatment of glaucoma
DE69232716T2 (de) Peptide mit thrombospondin-ähnlicher Aktivität und ihre therapeutische Verwendung
LV10108B (en) Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation
DE69425212T2 (de) Dem Motilin ähnliche Polypeptide mit stimulierender Wirkung auf den gastrointestinalen Trakt
AU636427C (en) Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
US9254306B2 (en) Eye drops
US20130085108A1 (en) Peptides for promoting angiogenesis and an use thereof
EP1458748B1 (fr) Peptides ayant un effet sur l'apoptose
WO1992016550A1 (fr) Composes d'organosoufre utiles pour traiter le glaucome